Intravenous Ketamine is proving to be a tremendous treatment for intractable depression as well as chronic pain. About half the patients treated respond positively with results lasting up to a week in most of the responders.
It has emerged as a treatment option for a variety of chronic pain conditions including fibromyalgia, small fiber neuropathy, Complex Regional Pain Syndrome (CRPS), Reflex Sympathetic Dystrophy (RSD) and psychiatric conditions including depression, Post Traumatic Stress Disorder (PTSD), suicidal ideation, and Obsessive-Compulsive Disorder (OCD).
Ketamine in the News
Remarkable secrets of ketamine’s antidepressant effect unlocked by scientists
Could Party Drug Ketamine Be a Treatment for Depression?
‘The fog is gone’: How ketamine could help lift hard-to-treat depression
Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.
Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
How does ketamine elicit a rapid antidepressant response?
The use of ketamine as an antidepressant: a systematic review and meta-analysis.
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
Do the dissociative side effects of ketamine mediate its antidepressant effects?
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.